A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non–small-cell lung cancer: a 5-year follow-up report
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference40 articles.
1. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer;Dillman;N Engl J. Med,1990
2. Radiotherapy alone versus combined chemotherapy and raditherapy in nonresectable non-small cell lung cancer;LeChevalier;J Natl Cancer Inst,1991
3. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer [see comments];Schaake-Koning;N Eng J Med,1992
4. Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma;Bleehen;Lung Cancer,1994
5. Radiation Therapy Oncology Group (RTOG 88–08) and Eastern Cooperative Oncology Group (ECOG) 4588;Sause;J Natl Cancer Inst,1995
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non–Small-Cell Lung Cancer;JAMA Oncology;2017-08-01
2. Postoperative Radiation Therapy for Non-Small Cell Lung Cancer and Thymic Malignancies;Cancers;2012-03-14
3. Acute Esophagitis and Late Lung Toxicity in Concurrent Chemoradiotherapy Trials in Patients with Locally Advanced Non–Small-Cell Lung Cancer: Analysis of the Radiation Therapy Oncology Group (RTOG) Database;Clinical Lung Cancer;2011-07
4. Radiotherapy and Second Generation Drugs;Medical Radiology;2011
5. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation;Radiotherapy and Oncology;2008-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3